Prespecified subgroup, sensitivity and specificity analyses Subgroup analyses were conducted based on gender, age, body mass index (BMI), HbA1c, DM status (pre-existing or post-transplant), post-transplant eGFR, the presence of hypertension, proteinuria, heart failure, obesity, enrollment time, prior history of GLP-1RAs uses before transplant, and the concurrent use of medications, including ACEIs/ARBs, antidiabetic agents (insulin, metformin, dipeptidyl peptidase-4 inhibitors (DPP-4is), sodium-glucose cotransporter 2 inhibitors (SGLT2is), and immunosuppressants (steroids, cyclosporine and tacrolimus)
The decision to prescribe is made by an independent UK-registered prescriber after a clinical assessment
It's unclear how safe semaglutide "would be for a person of normal weight." Join 350,000+ subscribers and keep yourself informed with a selection of The Weeks most interesting, enlightening and entertaining stories - plus daily puzzles
They will also check for side effects
That number would be dramatically higher if patients jumped straight to high doses
